Hip_Joint_Screening

Hip Joint Screening Set™

DDH Screening Data Analysis

Incidence rate disparity: Studies indicate DDH(Developmental Dysplasia of the Hip) incidence in underde veloped regions of China is 3.7/1000, compared to 1.5/1000 in developed regions, representing a 147% higher rate.
Genetic significance: Research demonstrates DDH heritability of approximately 70%, with first-degree relatives of DDH patients showing a 12-fold increased risk.
Early intervention outcomes: Treatment initiated within 3 months achieves >95% cure rate without surgical intervention, whereas treatment delayed beyond 6 months results in a 40% surgery rate.
Screening accessibility: Portable ultrasound screening devices can increase DDH screening rates in primary healthcare facilities from 15% to 85%, significantly improving early detection.
Global impact: WHO reports indicate early DDH diagnosis rates of only 30% in developing countries com pared to 90% in developed nations, emphasizing the importance of global screening implementation.

The Left hip is normal with the femoral head in the socket.

The right hip has DDH where the hip head is out of the socket.

Innovation in Motion:

Our technologically advanced examination station represents a breakthrough in infant hip ultrasound diagnosis. This integrated system features precision-engineered components, including our patented examination table, smart-positioning mattress, and advanced probe stabilization technology.

< 1/3 >

Key Advantages

Precision Engineering :

Our revolutionary probe stabilization system delivers superior accuracy, enabling consistent, reliable examinations.

Enhanced Safety :

Advanced infant positioning technology ensures optimal patient comfort and examination accuracy.

Clinical Flexibility :

Innovative modular design allows seamless integration into any clinical setting.